Hideaki Sato
Research Subjects
Hideaki Sato has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Akihiko Kitamura
Ajinomoto Co., Inc., Kawasaki 210-8681, Japan
2 shared publications - Akira Mitsui
Department of Gastroenterological Surgery Nagoya City University Graduate School of Medical Sciences Nagoya Japan
2 shared publications - Hiroyuki Takuwa
Quantum Neuromapping and Neuromodulation Team, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba, Japan
2 shared publications - Ichio Aoki
National Institutes for Quantum Science and Technology Anagawa 4-9-1, Inage
2 shared publications Keiichiro Minatohara
Department of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba 263-8555, Japan
2 shared publications- Kenji Nagao
Ajinomoto Co., Inc
2 shared publications
Latest Publications
- Open Access
- 22 October 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (43)
Neurodegenerative processes accelerated by protein malnutrition and decelerated by essential amino acids in a tauopathy mouse model
Intake of specific seven essential amino acids affects the pathology of the brain.
- 22 October 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (43)
Open AccessNeurodegenerative processes accelerated by protein malnutrition and decelerated by essential amino acids in a tauopathy mouse model
Intake of specific seven essential amino acids affects the pathology of the brain.
- Open Access
- 7 December 2020
- Published by Wiley in Alzheimer's & Dementia
- Vol. 16 (S2)
Tau‐induced brain atrophy and neuroinflammation accelerated by low‐protein diet and decelerated by selected essential amino acids in a murine model of tauopathies
Background: Nutritional epidemiology has implicated dietary protein intake in senile dementias. However, mechanistic links of protein and amino acids to age‐related neurodegenerative conditions remain unclear. Here, we tested the hypothesis that dietary intake of protein and amino acids could affect neuronal functions and survival in a mouse model of tauopathies, which develops tau pathologies leading to progressive brain atrophy with aging.Methods: Non‐transgenic (nTg) and tauopathy model (rTg4510) mice were fed a normal protein diet (NPD) or low protein diet (LPD) from 3 months of age, and brain volume and tau pathologies were measured at 6.5 months of age by MRI and PET, respectively. These imaging assays were also applied to NPD‐ and LPD‐fed mice treated with essential amino acids (EAAs), seven essential amino acids (EAAs), which are primarily composed of leucine, phenylalanine, and lysine with high fluxes into the brain and contain minimum levels of tryptophan, an origin of inflammation‐related kynurenine pathways. Moreover, we performed gene expression profiling of the cortical tissues collected from these mice.Results: LPD profoundly accelerated the brain atrophy in rTg4510 mice relative to NPD. EAA supplementation to rTg4510 mice markedly suppressed cortical volume reductions in both LPD‐ and NPD‐fed rTg4510. LPD and EAA did not overtly alter PET‐detectable tau depositions uncorrected for atrophy‐induced partial volume effects, raising a possibility of decreased tau burdens in each of surviving neurons to some extent. Gene expression profiling demonstrated neuroinflammatory changes and neuronal dysfunctions in rTg4510 mice, which were worsened by LPD and attenuated by EAAs. Notably, kynurenine levels were elevated by LPD, and this alteration was reversed by EEAs, presumably by competition between EEAs and kynurenine on the entry into the brain.Conclusion: Our findings highlight the critical roles of specific EEAs in the protection of neurons against tau‐induced toxicity and neuroinflammation.
- 7 December 2020
- Published by Wiley in Alzheimer's & Dementia
- Vol. 16 (S2)
Open AccessTau‐induced brain atrophy and neuroinflammation accelerated by low‐protein diet and decelerated by selected essential amino acids in a murine model of tauopathies
Background: Nutritional epidemiology has implicated dietary protein intake in senile dementias. However, mechanistic links of protein and amino acids to age‐related neurodegenerative conditions remain unclear. Here, we tested the hypothesis that dietary intake of protein and amino acids could affect neuronal functions and survival in a mouse model of tauopathies, which develops tau pathologies leading to progressive brain atrophy with aging.Methods: Non‐transgenic (nTg) and tauopathy model (rTg4510) mice were fed a normal protein diet (NPD) or low protein diet (LPD) from 3 months of age, and brain volume and tau pathologies were measured at 6.5 months of age by MRI and PET, respectively. These imaging assays were also applied to NPD‐ and LPD‐fed mice treated with essential amino acids (EAAs), seven essential amino acids (EAAs), which are primarily composed of leucine, phenylalanine, and lysine with high fluxes into the brain and contain minimum levels of tryptophan, an origin of inflammation‐related kynurenine pathways. Moreover, we performed gene expression profiling of the cortical tissues collected from these mice.Results: LPD profoundly accelerated the brain atrophy in rTg4510 mice relative to NPD. EAA supplementation to rTg4510 mice markedly suppressed cortical volume reductions in both LPD‐ and NPD‐fed rTg4510. LPD and EAA did not overtly alter PET‐detectable tau depositions uncorrected for atrophy‐induced partial volume effects, raising a possibility of decreased tau burdens in each of surviving neurons to some extent. Gene expression profiling demonstrated neuroinflammatory changes and neuronal dysfunctions in rTg4510 mice, which were worsened by LPD and attenuated by EAAs. Notably, kynurenine levels were elevated by LPD, and this alteration was reversed by EEAs, presumably by competition between EEAs and kynurenine on the entry into the brain.Conclusion: Our findings highlight the critical roles of specific EEAs in the protection of neurons against tau‐induced toxicity and neuroinflammation.
- 1 December 1998
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 253 (3) , 845-849
Autoxidation Rates of Neuronal Nitric Oxide Synthase: Effects of the Substrates, Inhibitors, and Modulators
- 1 December 1998
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 253 (3) , 845-849
Autoxidation Rates of Neuronal Nitric Oxide Synthase: Effects of the Substrates, Inhibitors, and Modulators